clinical trial · NCT05320198
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
Myelofibrosis; AnemiaAnemiaMyelofibrosisMyelofibrosis Due to and Following Polycythemia VeraPrimary MyelofibrosisPost-essential Thrombocythemia MyelofibrosisMyelodysplastic SyndromesDISC-0974
brief summary
This phase 1b/2a open-label study will evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and clinical activity of DISC-0974 as well as categorize the effects on hematologic response in participants with myelofibrosis or myelodysplastic syndrome and anemia.
started
Jun 6, 2022
primary completion
May 1, 2027
completion
Jun 1, 2027
last updated
Oct 22, 2026
official title
RALLY-MF: A Phase 1b/2 Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of DISC-0974 in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol